Emmanuel Margolin

557 total citations
20 papers, 410 citations indexed

About

Emmanuel Margolin is a scholar working on Virology, Biotechnology and Immunology. According to data from OpenAlex, Emmanuel Margolin has authored 20 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 10 papers in Biotechnology and 10 papers in Immunology. Recurrent topics in Emmanuel Margolin's work include Transgenic Plants and Applications (10 papers), Toxin Mechanisms and Immunotoxins (8 papers) and HIV Research and Treatment (7 papers). Emmanuel Margolin is often cited by papers focused on Transgenic Plants and Applications (10 papers), Toxin Mechanisms and Immunotoxins (8 papers) and HIV Research and Treatment (7 papers). Emmanuel Margolin collaborates with scholars based in South Africa, United Kingdom and Austria. Emmanuel Margolin's co-authors include Rosamund Chapman, Edward P. Rybicki, Anna‐Lise Williamson, Ann E. Meyers, Michiel T. van Diepen, Richard Strasser, Nicola Douglass, Penny L. Moore, Max Crispin and Lynn Morris and has published in prestigious journals such as PLoS ONE, Nature Reviews Microbiology and Journal of Virology.

In The Last Decade

Emmanuel Margolin

20 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Margolin South Africa 12 256 216 156 109 89 20 410
Audrey Y‐H. Teh United Kingdom 13 324 1.3× 273 1.3× 122 0.8× 57 0.5× 82 0.9× 18 423
Matthew Dent United States 10 233 0.9× 248 1.1× 83 0.5× 107 1.0× 116 1.3× 12 445
Anlan Dai United States 10 116 0.5× 174 0.8× 213 1.4× 61 0.6× 27 0.3× 17 415
Hugh Haydon United States 7 308 1.2× 261 1.2× 71 0.5× 59 0.5× 97 1.1× 7 377
April Horsey Sweden 8 424 1.7× 340 1.6× 108 0.7× 145 1.3× 162 1.8× 8 532
Andrew G. Diamos United States 10 224 0.9× 227 1.1× 71 0.5× 65 0.6× 127 1.4× 14 345
A. Modelska United States 5 580 2.3× 501 2.3× 105 0.7× 121 1.1× 214 2.4× 6 669
Annie Séguin Canada 3 211 0.8× 183 0.8× 115 0.7× 183 1.7× 61 0.7× 3 394
Jonathan Hurtado United States 9 333 1.3× 285 1.3× 84 0.5× 93 0.9× 148 1.7× 11 461
Stephen L. Hoffman United States 6 159 0.6× 218 1.0× 75 0.5× 18 0.2× 144 1.6× 9 418

Countries citing papers authored by Emmanuel Margolin

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Margolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Margolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Margolin more than expected).

Fields of papers citing papers by Emmanuel Margolin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Margolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Margolin. The network helps show where Emmanuel Margolin may publish in the future.

Co-authorship network of co-authors of Emmanuel Margolin

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Margolin. A scholar is included among the top collaborators of Emmanuel Margolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Margolin. Emmanuel Margolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williamson, Anna‐Lise, Georgia Schäfer, Nicola Douglass, et al.. (2023). LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters. Viruses. 15(7). 1409–1409. 4 indexed citations
2.
Chapman, Rosamund, Nicola Douglass, Mohamed Jaffer, et al.. (2023). Development of a dual vaccine against East Coast fever and lumpy skin disease. Frontiers in Immunology. 14. 1143034–1143034. 4 indexed citations
3.
Margolin, Emmanuel, Georgia Schäfer, Joel D. Allen, et al.. (2023). A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters. Frontiers in Plant Science. 14. 1146234–1146234. 15 indexed citations
4.
Chapman, Rosamund, Ann E. Meyers, Emmanuel Margolin, et al.. (2022). Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein. Nanotechnology. 33(48). 485102–485102. 6 indexed citations
5.
Margolin, Emmanuel, Rosamund Chapman, Ann E. Meyers, et al.. (2022). Investigating Constraints Along the Plant Secretory Pathway to Improve Production of a SARS-CoV-2 Spike Vaccine Candidate. Frontiers in Plant Science. 12. 798822–798822. 12 indexed citations
6.
Margolin, Emmanuel, Joel D. Allen, Rosamund Chapman, et al.. (2022). Augmenting glycosylation‐directed folding pathways enhances the fidelity of HIV Env immunogen production in plants. Biotechnology and Bioengineering. 119(10). 2919–2937. 9 indexed citations
7.
Shin, Yun‐Ji, Ulrike Vavra, Miriam Klausberger, et al.. (2021). N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in Plants. Frontiers in Plant Science. 12. 689104–689104. 44 indexed citations
8.
Margolin, Emmanuel, Joel D. Allen, Michiel T. van Diepen, et al.. (2021). Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana. Frontiers in Plant Science. 12. 709344–709344. 11 indexed citations
9.
Chapman, Rosamund, Michiel T. van Diepen, Nicola Douglass, et al.. (2021). Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV. Vaccines. 9(11). 1281–1281. 7 indexed citations
10.
Margolin, Emmanuel, Yulia Meshcheriakova, Hadrien Peyret, et al.. (2020). Co‐expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants. Plant Biotechnology Journal. 18(10). 2109–2117. 49 indexed citations
11.
Chapman, Rosamund, Ann E. Meyers, Emmanuel Margolin, et al.. (2020). Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens. Frontiers in Bioengineering and Biotechnology. 8. 321–321. 5 indexed citations
12.
Margolin, Emmanuel, Richard Strasser, Rosamund Chapman, et al.. (2020). Engineering the Plant Secretory Pathway for the Production of Next-Generation Pharmaceuticals. Trends in biotechnology. 38(9). 1034–1044. 39 indexed citations
13.
Margolin, Emmanuel, Max Crispin, Ann E. Meyers, Rosamund Chapman, & Edward P. Rybicki. (2020). A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding. Frontiers in Plant Science. 11. 609207–609207. 20 indexed citations
14.
Margolin, Emmanuel, Wendy A. Burgers, Edward D. Sturrock, et al.. (2020). Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa. Nature Reviews Microbiology. 18(12). 690–704. 42 indexed citations
15.
Douglass, Nicola, Michiel T. van Diepen, Rosamund Chapman, et al.. (2020). Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity. Vaccine. 39(3). 463–468. 1 indexed citations
16.
Chapman, Rosamund, Michiel T. van Diepen, Elizabeth Kruse, et al.. (2020). Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles. Vaccines. 8(1). 54–54. 13 indexed citations
17.
Margolin, Emmanuel, Rosamund Chapman, Ann E. Meyers, et al.. (2019). Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens. Frontiers in Plant Science. 10. 1378–1378. 26 indexed citations
18.
Diepen, Michiel T. van, Rosamund Chapman, Nicola Douglass, et al.. (2019). Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus. Journal of Virology. 93(8). 29 indexed citations
19.
Diepen, Michiel T. van, Rosamund Chapman, Penny L. Moore, et al.. (2018). The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256. PLoS ONE. 13(12). e0208310–e0208310. 16 indexed citations
20.
Margolin, Emmanuel, Rosamund Chapman, Anna‐Lise Williamson, Edward P. Rybicki, & Ann E. Meyers. (2018). Production of complex viral glycoproteins in plants as vaccine immunogens. Plant Biotechnology Journal. 16(9). 1531–1545. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Audrey Y‐H. Teh Breakdown of academic impact, for papers by Matthew Dent Breakdown of academic impact, for papers by Anlan Dai Breakdown of academic impact, for papers by Hugh Haydon Breakdown of academic impact, for papers by April Horsey Breakdown of academic impact, for papers by Andrew G. Diamos Breakdown of academic impact, for papers by A. Modelska Breakdown of academic impact, for papers by Annie Séguin Breakdown of academic impact, for papers by Jonathan Hurtado Breakdown of academic impact, for papers by Stephen L. Hoffman
Rankless by CCL
2026